Article
Biosimilar FSH preparations- are they identical twins or just siblings?
14 Jun 2016
Abstract excerpt
As patents expire on innovator products, there is increasing interest in developing biosimilar products globally. Biosimilars are not exact copies and are not considered generic versions of the reference product. They may differ in strength, purity and contain different composition of isoforms and/or various glycosylation profiles, with the consequent alterations in clinical efficacy or safety. Recently 2 new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
